tousled1
12-16-2007, 04:50 AM
Data presented at the 30th Annual San Antonio Breast Cancer Symposium confirm that Herceptin is the standard of care for women with HER2-positive breast cancer across all stages of the disease
Full article:
http://www.presseportal.de/pm/24678/1103570/roche_pharmaceuticals
Full article:
http://www.presseportal.de/pm/24678/1103570/roche_pharmaceuticals